Targeted Delivery Drugs Market by Type and Application - Global Industry Analysis & Forecast to 2027

Published On : December 2019 Pages : 146 Category: Medical Devices Report Code : HC127430

SEGMENTS & REGIONS:

Regions: North America, Europe, Asia- Pacific, Latin America, Middle East & Africa

Report Description
Table of Content

Targeted Delivery Drugs Market By Type (Ocular Drug Delivery, Drug Eluting Stents, Pulmonary Drug Delivery, Other) and Application (Hospital, Clinic, Other) - Global Industry Analysis & Forecast to 2027

Industry Outlook and Trend Analysis

The Targeted Delivery Drugs Market has encountered significant development over the recent years and is anticipated to grow tremendously over the forecast period. Targeted delivery of drugs is defined as a method of injecting drugs into the body so that they only target specific parts of the body. Targeted delivery of drugs is designed to target, extend and protect interactions with diseased tissues.

Drivers and Restraints

Top-down and bottom-up approaches are used to validate the global Targeted Delivery Drugs Market size market and estimate the market size for company, regions segments, type segments and applications (end users). In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.

Regional Insights

The data for 2021 is an estimate, based on the history data and the integrated view of industry experts, manufacturers, distributors and end users etc.

By Region

North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
Asia-Pacific
- China
- Japan
- South Korea
- India
- Southeast Asia
- Rest of Asia-Pacific
South America
- Brazil
- Argentina
- Columbia
- Rest of South America
Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Nigeria
- South Africa
- Rest of MEA

Competitive Analysis

The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.

Adverum
Arrowhead Pharmaceuticals
Bayer
Windtree Therapeutics
Immunocore
Mankind Pharma
Roche

Some of the key questions answered by the report are:

What was the market size in 2017 and forecast from 2017 to 2027?
What will be the industry market growth from 2017 to 2027?
What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
What are the major segments leading the market growth and why?
Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?

Market Classification

· Targeted Delivery Drugs Market, By Type, Estimates and Forecast, 2017-2027 ($Million)

o Ocular Drug Delivery

o Drug Eluting Stents

o Pulmonary Drug Delivery

o Other

· Targeted Delivery Drugs Market, By Application, Estimates and Forecast, 2017-2027 ($Million)

o Hospital

o Clinic

o Other

· Targeted Delivery Drugs Market, By Key Players, Estimates and Forecast, 2017-2027 ($Million)

o Adverum

o Arrowhead Pharmaceuticals

o Bayer

o Windtree Therapeutics

o Immunocore

o Mankind Pharma

o Roche

· Targeted Delivery Drugs Market, By Region, Estimates and Forecast, 2017-2027 ($Million)

o North America

§ North America Targeted Delivery Drugs Market, By Country

o U.S. Targeted Delivery Drugs Market

o Canada Targeted Delivery Drugs Market

o Mexico Targeted Delivery Drugs Market

o Europe

§ Europe Targeted Delivery Drugs Market, By Country

o Germany Targeted Delivery Drugs Market

o UK Targeted Delivery Drugs Market

o France Targeted Delivery Drugs Market

o Russia Targeted Delivery Drugs Market

o Italy Targeted Delivery Drugs Market

o Rest of Europe Targeted Delivery Drugs Market

o Asia-Pacific

§ Asia-Pacific Targeted Delivery Drugs Market, By Country

o China Targeted Delivery Drugs Market

o Japan Targeted Delivery Drugs Market

o South Korea Targeted Delivery Drugs Market

o India Targeted Delivery Drugs Market

o Southeast Asia Targeted Delivery Drugs Market

o Rest of Asia-Pacific Targeted Delivery Drugs Market

o South America

§ South America Targeted Delivery Drugs Market

o Brazil Targeted Delivery Drugs Market

o Argentina Targeted Delivery Drugs Market

o Columbia Targeted Delivery Drugs Market

o Rest of South America Targeted Delivery Drugs Market

o Middle East and Africa

§ Middle East and Africa Targeted Delivery Drugs Market

o Saudi Arabia Targeted Delivery Drugs Market

o UAE Targeted Delivery Drugs Market

o Egypt Targeted Delivery Drugs Market

o Nigeria Targeted Delivery Drugs Market

o South Africa Targeted Delivery Drugs Market

o Rest of MEA Targeted Delivery Drugs Market

Table of Contents:

1. Introduction

1.1. Report Description

2. Executive Summary

2.1. Key Highlights

3. Market Overview

3.1. Introduction

3.1.1. Market Definition

3.1.2. Market Segmentation

3.2. Market Dynamics

3.2.1. Drivers

3.2.2. Restraints

3.2.3. Opportunities

4. Market Analysis by Regions

4.1. North America (United States, Canada and Mexico)

4.1.1. United States Market Status and Outlook (2017-2027)

4.1.2. Canada Market Status and Outlook (2017-2027)

4.1.3. Mexico Market Status and Outlook (2017-2027)

4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

4.2.1. Germany Market Status and Outlook (2017-2027)

4.2.2. France Market Status and Outlook (2017-2027)

4.2.3. UK Market Status and Outlook (2017-2027)

4.2.4. Russia Market Status and Outlook (2017-2027)

4.2.5. Italy Market Status and Outlook (2017-2027)

4.2.6. Rest of Europe Market Status and Outlook (2017-2027)

4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)

4.3.1. China Market Status and Outlook (2017-2027)

4.3.2. Japan Market Status and Outlook (2017-2027)

4.3.3. Korea Market Status and Outlook (2017-2027)

4.3.4. India Market Status and Outlook (2017-2027)

4.3.5. Southeast Asia Market Status and Outlook (2017-2027)

4.3.6. Rest of Asia-Pacific Market Status and Outlook (2017-2027)

4.4. South America (Brazil, Argentina, Columbia and Rest of South America)

4.4.1. Brazil Market Status and Outlook (2017-2027)

4.4.2. Argentina Market Status and Outlook (2017-2027)

4.4.3. Columbia Market Status and Outlook (2017-2027)

4.4.4. Rest of South America Market Status and Outlook (2017-2027)

4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)

4.5.1. Saudi Arabia Market Status and Outlook (2017-2027)

4.5.2. United Arab Emirates Market Status and Outlook (2017-2027)

4.5.3. Egypt Market Status and Outlook (2017-2027)

4.5.4. Nigeria Market Status and Outlook (2017-2027)

4.5.5. South Africa Market Status and Outlook (2017-2027)

4.5.6. Turkey Market Status and Outlook (2017-2027)

4.5.7. Rest of Middle East and Africa Market Status and Outlook (2017-2027)

5. Targeted Delivery Drugs Market, By Type

5.1. Introduction

5.2. Global Targeted Delivery Drugs Revenue and Market Share by Type (2017-2027)

5.2.1. Global Targeted Delivery Drugs Revenue and Revenue Share by Type (2017-2027)

5.3. Ocular Drug Delivery

5.3.1. Global Ocular Drug Delivery Revenue and Growth Rate (2017-2027)

5.4. Drug Eluting Stents

5.4.1. Global Drug Eluting Stents Revenue and Growth Rate (2017-2027)

5.5. Pulmonary Drug Delivery

5.5.1. Global Pulmonary Drug Delivery Revenue and Growth Rate (2017-2027)

5.6. Other

5.6.1. Global Other Revenue and Growth Rate (2017-2027)

6. Targeted Delivery Drugs Market, By Application

6.1. Introduction

6.2. Global Targeted Delivery Drugs Revenue and Market Share by Application (2017-2027)

6.2.1. Global Targeted Delivery Drugs Revenue and Revenue Share by Application (2017-2027)

6.3. Hospital

6.3.1. Global Hospital Revenue and Growth Rate (2017-2027)

6.4. Clinic

6.4.1. Global Clinic Revenue and Growth Rate (2017-2027)

6.5. Other

6.5.1. Global Other Revenue and Growth Rate (2017-2027)

7. Targeted Delivery Drugs Market, By Region

7.1. Introduction

7.2. Global Targeted Delivery Drugs Revenue and Market Share by Regions

7.2.1. Global Targeted Delivery Drugs Revenue by Regions (2017-2027)

7.3. North America Targeted Delivery Drugs by Countries

7.3.1. North America Targeted Delivery Drugs Revenue and Growth Rate (2017-2027)

7.3.2. North America Targeted Delivery Drugs Revenue (Million USD) by Countries (2017-2027)

7.3.3. United States

7.3.3.1. United States Targeted Delivery Drugs Revenue (Millions USD) and Growth Rate (2017-2027)

7.3.4. Canada

7.3.4.1. Canada Targeted Delivery Drugs Revenue (Millions USD) and Growth Rate (2017-2027)

7.3.5. Mexico

7.3.5.1. Mexico Targeted Delivery Drugs Revenue (Millions USD) and Growth Rate (2017-2027)

7.4. Europe Targeted Delivery Drugs by Countries

7.4.1. Europe Targeted Delivery Drugs Revenue and Growth Rate (2017-2027)

7.4.2. Europe Targeted Delivery Drugs Revenue (Million USD) by Countries (2017-2027)

7.4.3. Germany

7.4.3.1. Germany Targeted Delivery Drugs Revenue (Millions USD) and Growth Rate (2017-2027)

7.4.4. France

7.4.4.1. France Targeted Delivery Drugs Revenue (Millions USD) and Growth Rate (2017-2027)

7.4.5. UK

7.4.5.1. UK Targeted Delivery Drugs Revenue (Millions USD) and Growth Rate (2017-2027)

7.4.6. Russia

7.4.6.1. Russia Targeted Delivery Drugs Revenue (Millions USD) and Growth Rate (2017-2027)

7.4.7. Italy

7.4.7.1. Italy Targeted Delivery Drugs Revenue (Millions USD) and Growth Rate (2017-2027)

7.4.8. Rest of Europe

7.4.8.1. Rest of Europe Targeted Delivery Drugs Revenue (Millions USD) and Growth Rate (2017-2027)

7.5. Asia-Pacific Targeted Delivery Drugs by Countries

7.5.1. Asia-Pacific Targeted Delivery Drugs Revenue and Growth Rate (2017-2027)

7.5.2. Asia-Pacific Targeted Delivery Drugs Revenue (Million USD) by Countries (2017-2027)

7.5.3. China

7.5.3.1. China Targeted Delivery Drugs Revenue (Millions USD) and Growth Rate (2017-2027)

7.5.4. Japan

7.5.4.1. Japan Targeted Delivery Drugs Revenue (Millions USD) and Growth Rate (2017-2027)

7.5.5. Korea

7.5.5.1. Korea Targeted Delivery Drugs Revenue (Millions USD) and Growth Rate (2017-2027)

7.5.6. India

7.5.6.1. India Targeted Delivery Drugs Revenue (Millions USD) and Growth Rate (2017-2027)

7.5.7. Southeast Asia

7.5.7.1. Southeast Asia Targeted Delivery Drugs Revenue (Millions USD) and Growth Rate (2017-2027)

7.5.8. Rest of Asia-Pacific

7.5.8.1. Rest of Asia-Pacific Targeted Delivery Drugs Revenue (Millions USD) and Growth Rate (2017-2027)

7.6. South America Targeted Delivery Drugs by Countries

7.6.1. South America Targeted Delivery Drugs Revenue and Growth Rate (2017-2027)

7.6.2. South America Targeted Delivery Drugs Revenue (Million USD) by Countries (2017-2027)

7.6.3. Brazil

7.6.3.1. Brazil Targeted Delivery Drugs Revenue (Millions USD) and Growth Rate (2017-2027)

7.6.4. Argentina

7.6.4.1. Argentina Targeted Delivery Drugs Revenue (Millions USD) and Growth Rate (2017-2027)

7.6.5. Columbia

7.6.5.1. Columbia Targeted Delivery Drugs Revenue (Millions USD) and Growth Rate (2017-2027)

7.6.6. Rest of South America

7.6.6.1. Rest of South America Targeted Delivery Drugs Revenue (Millions USD) and Growth Rate (2017-2027)

7.7. Middle East and Africa Targeted Delivery Drugs by Countries

7.7.1. Middle East and Africa Targeted Delivery Drugs Revenue and Growth Rate (2017-2027)

7.7.2. Middle East and Africa Targeted Delivery Drugs Revenue (Million USD) by Countries (2017-2027)

7.7.3. Saudi Arabia

7.7.3.1. Saudi Arabia Targeted Delivery Drugs Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.4. United Arab Emirates

7.7.4.1. United Arab Emirates Targeted Delivery Drugs Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.5. Egypt

7.7.5.1. Egypt Targeted Delivery Drugs Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.6. Nigeria

7.7.6.1. Nigeria Targeted Delivery Drugs Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.7. South Africa

7.7.7.1. South Africa Targeted Delivery Drugs Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.8. Turkey

7.7.8.1. Turkey Targeted Delivery Drugs Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.9. Rest of Middle East and Africa

7.7.9.1. Rest of Middle East and Africa Targeted Delivery Drugs Revenue (Millions USD) and Growth Rate (2017-2027)

8. Company Profiles

8.1. Adverum

8.1.1. Business Overview

8.1.2. Service Portfolio

8.1.3. Strategic Developments

8.1.4. Financial Overview

8.2. Arrowhead Pharmaceuticals

8.2.1. Business Overview

8.2.2. Service Portfolio

8.2.3. Strategic Developments

8.2.4. Financial Overview

8.3. Bayer

8.3.1. Business Overview

8.3.2. Service Portfolio

8.3.3. Strategic Developments

8.3.4. Financial Overview

8.4. Windtree Therapeutics

8.4.1. Business Overview

8.4.2. Service Portfolio

8.4.3. Strategic Developments

8.4.4. Financial Overview

8.5. Immunocore

8.5.1. Business Overview

8.5.2. Service Portfolio

8.5.3. Strategic Developments

8.5.4. Financial Overview

8.6. Mankind Pharma

8.6.1. Business Overview

8.6.2. Service Portfolio

8.6.3. Strategic Developments

8.6.4. Financial Overview

8.7. Roche

8.7.1. Business Overview

8.7.2. Service Portfolio

8.7.3. Strategic Developments

8.7.4. Financial Overview

9. Targeted Delivery Drugs Market Forecast (2017-2027)

9.1. Global Targeted Delivery Drugs Revenue (Millions USD) and Growth Rate (2017-2027)

9.2. Targeted Delivery Drugs Market Forecast by Regions (2017-2027)

9.2.1. North America Targeted Delivery Drugs Market Forecast (2017-2027)

9.2.1.1. United States Targeted Delivery Drugs Market Forecast (2017-2027)

9.2.1.2. Canada Targeted Delivery Drugs Market Forecast (2017-2027)

9.2.1.3. Mexico Targeted Delivery Drugs Market Forecast (2017-2027)

9.2.2. Europe Targeted Delivery Drugs Market Forecast (2017-2027)

9.2.2.1. Germany Targeted Delivery Drugs Market Forecast (2017-2027)

9.2.2.2. France Targeted Delivery Drugs Market Forecast (2017-2027)

9.2.2.3. UK Targeted Delivery Drugs Market Forecast (2017-2027)

9.2.2.4. Russia Targeted Delivery Drugs Market Forecast (2017-2027)

9.2.2.5. Italy Targeted Delivery Drugs Market Forecast (2017-2027)

9.2.2.6. Rest of Europe Targeted Delivery Drugs Market Forecast (2017-2027)

9.2.3. Asia-Pacific Targeted Delivery Drugs Market Forecast (2017-2027)

9.2.3.1. China Targeted Delivery Drugs Market Forecast (2017-2027)

9.2.3.2. Japan Targeted Delivery Drugs Market Forecast (2017-2027)

9.2.3.3. Korea Targeted Delivery Drugs Market Forecast (2017-2027)

9.2.3.4. India Targeted Delivery Drugs Market Forecast (2017-2027)

9.2.3.5. Southeast Asia Targeted Delivery Drugs Market Forecast (2017-2027)

9.2.3.6. Rest of Asia-Pacific Targeted Delivery Drugs Market Forecast (2017-2027)

9.2.4. South America Targeted Delivery Drugs Market Forecast (2017-2027)

9.2.4.1. Brazil Targeted Delivery Drugs Market Forecast (2017-2027)

9.2.4.2. Argentina Targeted Delivery Drugs Market Forecast (2017-2027)

9.2.4.3. Columbia Targeted Delivery Drugs Market Forecast (2017-2027)

9.2.4.4. Rest of South America Targeted Delivery Drugs Market Forecast (2017-2027)

9.2.5. Middle East and Africa Targeted Delivery Drugs Market Forecast (2017-2027)

9.2.5.1. Saudi Arabia Targeted Delivery Drugs Market Forecast (2017-2027)

9.2.5.2. United Arab Emirates Targeted Delivery Drugs Market Forecast (2017-2027)

9.2.5.3. Egypt Targeted Delivery Drugs Market Forecast (2017-2027)

9.2.5.4. Nigeria Targeted Delivery Drugs Market Forecast (2017-2027)

9.2.5.5. South Africa Targeted Delivery Drugs Market Forecast (2017-2027)

9.2.5.6. Turkey Targeted Delivery Drugs Market Forecast (2017-2027)

9.2.5.7. Rest of Middle East and Africa Targeted Delivery Drugs Market Forecast (2017-2027)

9.3. Targeted Delivery Drugs Market Forecast by Type (2017-2027)

9.3.1. Targeted Delivery Drugs Forecast by Type (2017-2027)

9.3.2. Targeted Delivery Drugs Market Share Forecast by Type (2017-2027)

9.4. Targeted Delivery Drugs Market Forecast by Application (2017-2027)

9.4.1. Targeted Delivery Drugs Forecast by Application (2017-2027)

9.4.2. Targeted Delivery Drugs Market Share Forecast by Application (2017-2027)

List of Tables

List of Tables and Figures:

Figure United States Targeted Delivery Drugs Revenue (Million USD) and Growth Rate (2017-2025)
Figure Canada Targeted Delivery Drugs Revenue (Million USD) and Growth Rate (2017-2025)
Figure Mexico Targeted Delivery Drugs Revenue (Million USD) and Growth Rate (2017-2025)
Figure Germany Targeted Delivery Drugs Revenue (Million USD) and Growth Rate (2017-2025)
Figure France Targeted Delivery Drugs Revenue (Million USD) and Growth Rate (2017-2025)
Figure UK Targeted Delivery Drugs Revenue (Million USD) and Growth Rate (2017-2025)
Figure Russia Targeted Delivery Drugs Revenue (Million USD) and Growth Rate (2017-2025)
Figure Italy Targeted Delivery Drugs Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Europe Targeted Delivery Drugs Revenue (Million USD) and Growth Rate (2017-2025)
Figure China Targeted Delivery Drugs Revenue (Million USD) and Growth Rate (2017-2025)
Figure Japan Targeted Delivery Drugs Revenue (Million USD) and Growth Rate (2017-2025)
Figure Korea Targeted Delivery Drugs Revenue (Million USD) and Growth Rate (2017-2025)
Figure India Targeted Delivery Drugs Revenue (Million USD) and Growth Rate (2017-2025)
Figure Southeast Asia Targeted Delivery Drugs Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Asia-Pacific Targeted Delivery Drugs Revenue (Million USD) and Growth Rate (2017-2025)
Figure Brazil Targeted Delivery Drugs Revenue (Million USD) and Growth Rate (2017-2025)
Figure Argentina Targeted Delivery Drugs Revenue (Million USD) and Growth Rate (2017-2025)
Figure Columbia Targeted Delivery Drugs Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of South America Targeted Delivery Drugs Revenue (Million USD) and Growth Rate (2017-2025)
Figure Saudi Arabia Targeted Delivery Drugs Revenue (Million USD) and Growth Rate (2017-2025)
Figure United Arab Emirates Targeted Delivery Drugs Revenue (Million USD) and Growth Rate (2017-2025)
Figure Egypt Targeted Delivery Drugs Revenue (Million USD) and Growth Rate (2017-2025)
Figure Nigeria Targeted Delivery Drugs Revenue (Million USD) and Growth Rate (2017-2025)
Figure South Africa Targeted Delivery Drugs Revenue (Million USD) and Growth Rate (2017-2025)
Figure Turkey Targeted Delivery Drugs Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Middle East and Africa Targeted Delivery Drugs Revenue (Million USD) and Growth Rate (2017-2025)
Table Global Targeted Delivery Drugs Revenue and Revenue Share by Type (2017-2018)
Figure Global Ocular Drug Delivery Revenue and Growth Rate (2017-2018)
Figure Global Drug Eluting Stents Revenue and Growth Rate (2017-2018)
Figure Global Pulmonary Drug Delivery Revenue and Growth Rate (2017-2018)
Figure Global Other Revenue and Growth Rate (2017-2018)
Table Global Targeted Delivery Drugs Revenue and Revenue Share by Application (2017-2018)
Figure Global Hospital Revenue and Growth Rate (2017-2018)
Figure Global Clinic Revenue and Growth Rate (2017-2018)
Figure Global Other Revenue and Growth Rate (2017-2018)
Table Global Targeted Delivery Drugs Revenue by Regions (2017-2018)
Figure North America Targeted Delivery Drugs Growth Rate (2017-2018)
Figure North America Targeted Delivery Drugs Revenue and Growth Rate (2017-2018)
Figure North America Targeted Delivery Drugs by Countries (2017-2018)
Figure North America Targeted Delivery Drugs Revenue (Million USD) by Countries (2017-2018)
Figure United States Targeted Delivery Drugs Growth Rate (2017-2018)
Figure United States Targeted Delivery Drugs Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Canada Targeted Delivery Drugs Growth Rate (2017-2018)
Figure Canada Targeted Delivery Drugs Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Mexico Targeted Delivery Drugs Growth Rate (2017-2018)
Figure Mexico Targeted Delivery Drugs Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Europe Targeted Delivery Drugs Growth Rate (2017-2018)
Figure Europe Targeted Delivery Drugs Revenue and Growth Rate (2017-2018)
Figure Europe Targeted Delivery Drugs by Countries (2017-2018)
Figure Europe Targeted Delivery Drugs Revenue (Million USD) by Countries (2017-2018)
Figure Germany Targeted Delivery Drugs Growth Rate (2017-2018)
Figure Germany Targeted Delivery Drugs Revenue (Millions USD) and Growth Rate (2017-2018)
Figure France Targeted Delivery Drugs Growth Rate (2017-2018)
Figure France Targeted Delivery Drugs Revenue (Millions USD) and Growth Rate (2017-2018)
Figure UK Targeted Delivery Drugs Growth Rate (2017-2018)
Figure UK Targeted Delivery Drugs Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Russia Targeted Delivery Drugs Growth Rate (2017-2018)
Figure Russia Targeted Delivery Drugs Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Italy Targeted Delivery Drugs Growth Rate (2017-2018)
Figure Italy Targeted Delivery Drugs Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Europe Targeted Delivery Drugs Growth Rate (2017-2018)
Figure Rest of Europe Targeted Delivery Drugs Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Asia-Pacific Targeted Delivery Drugs Growth Rate (2017-2018)
Figure Asia-Pacific Targeted Delivery Drugs Revenue and Growth Rate (2017-2018)
Figure Asia-Pacific Targeted Delivery Drugs by Countries (2017-2018)
Figure Asia-Pacific Targeted Delivery Drugs Revenue (Million USD) by Countries (2017-2018)
Figure China Targeted Delivery Drugs Growth Rate (2017-2018)
Figure China Targeted Delivery Drugs Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Japan Targeted Delivery Drugs Growth Rate (2017-2018)
Figure Japan Targeted Delivery Drugs Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Korea Targeted Delivery Drugs Growth Rate (2017-2018)
Figure Korea Targeted Delivery Drugs Revenue (Millions USD) and Growth Rate (2017-2018)
Figure India Targeted Delivery Drugs Growth Rate (2017-2018)
Figure India Targeted Delivery Drugs Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Southeast Asia Targeted Delivery Drugs Growth Rate (2017-2018)
Figure Southeast Asia Targeted Delivery Drugs Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Targeted Delivery Drugs Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Targeted Delivery Drugs Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South America Targeted Delivery Drugs Growth Rate (2017-2018)
Figure South America Targeted Delivery Drugs Revenue and Growth Rate (2017-2018)
Figure South America Targeted Delivery Drugs by Countries (2017-2018)
Figure South America Targeted Delivery Drugs Revenue (Million USD) by Countries (2017-2018)
Figure Brazil Targeted Delivery Drugs Growth Rate (2017-2018)
Figure Brazil Targeted Delivery Drugs Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Argentina Targeted Delivery Drugs Growth Rate (2017-2018)
Figure Argentina Targeted Delivery Drugs Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Columbia Targeted Delivery Drugs Growth Rate (2017-2018)
Figure Columbia Targeted Delivery Drugs Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of South America Targeted Delivery Drugs Growth Rate (2017-2018)
Figure Rest of South America Targeted Delivery Drugs Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Middle East and Africa Targeted Delivery Drugs Growth Rate (2017-2018)
Figure Middle East and Africa Targeted Delivery Drugs Revenue and Growth Rate (2017-2018)
Figure Middle East and Africa Targeted Delivery Drugs by Countries (2017-2018)
Figure Middle East and Africa Targeted Delivery Drugs Revenue (Million USD) by Countries (2017-2018)
Figure Saudi Arabia Targeted Delivery Drugs Growth Rate (2017-2018)
Figure Saudi Arabia Targeted Delivery Drugs Revenue (Millions USD) and Growth Rate (2017-2018)
Figure United Arab Emirates Targeted Delivery Drugs Growth Rate (2017-2018)
Figure United Arab Emirates Targeted Delivery Drugs Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Egypt Targeted Delivery Drugs Growth Rate (2017-2018)
Figure Egypt Targeted Delivery Drugs Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Nigeria Targeted Delivery Drugs Growth Rate (2017-2018)
Figure Nigeria Targeted Delivery Drugs Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South Africa Targeted Delivery Drugs Growth Rate (2017-2018)
Figure South Africa Targeted Delivery Drugs Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Turkey Targeted Delivery Drugs Growth Rate (2017-2018)
Figure Turkey Targeted Delivery Drugs Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Targeted Delivery Drugs Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Targeted Delivery Drugs Revenue (Millions USD) and Growth Rate (2017-2018)
Table Adverum Targeted Delivery Drugs Financial Overview
Table Arrowhead Pharmaceuticals Targeted Delivery Drugs Financial Overview
Table Bayer Targeted Delivery Drugs Financial Overview
Table Windtree Therapeutics Targeted Delivery Drugs Financial Overview
Table Immunocore Targeted Delivery Drugs Financial Overview
Table Mankind Pharma Targeted Delivery Drugs Financial Overview
Table Roche Targeted Delivery Drugs Financial Overview
Figure Global Targeted Delivery Drugs Revenue (Millions USD) and Growth Rate (2018-2025)
Table Targeted Delivery Drugs Market Forecast by Regions (2018-2025)
Figure North America Targeted Delivery Drugs Market Forecast (2018-2025)
Figure United States Targeted Delivery Drugs Market Forecast (2018-2025)
Figure Canada Targeted Delivery Drugs Market Forecast (2018-2025)
Figure Mexico Targeted Delivery Drugs Market Forecast (2018-2025)
Figure Europe Targeted Delivery Drugs Market Forecast (2018-2025)
Figure Germany Targeted Delivery Drugs Market Forecast (2018-2025)
Figure France Targeted Delivery Drugs Market Forecast (2018-2025)
Figure UK Targeted Delivery Drugs Market Forecast (2018-2025)
Figure Russia Targeted Delivery Drugs Market Forecast (2018-2025)
Figure Italy Targeted Delivery Drugs Market Forecast (2018-2025)
Figure Rest of Europe Targeted Delivery Drugs Market Forecast (2018-2025)
Figure Asia-Pacific Targeted Delivery Drugs Market Forecast (2018-2025)
Figure China Targeted Delivery Drugs Market Forecast (2018-2025)
Figure Japan Targeted Delivery Drugs Market Forecast (2018-2025)
Figure Korea Targeted Delivery Drugs Market Forecast (2018-2025)
Figure India Targeted Delivery Drugs Market Forecast (2018-2025)
Figure Southeast Asia Targeted Delivery Drugs Market Forecast (2018-2025)
Figure Rest of Asia-Pacific Targeted Delivery Drugs Market Forecast (2018-2025)
Figure South America Targeted Delivery Drugs Market Forecast (2018-2025)
Figure Brazil Targeted Delivery Drugs Market Forecast (2018-2025)
Figure Argentina Targeted Delivery Drugs Market Forecast (2018-2025)
Figure Columbia Targeted Delivery Drugs Market Forecast (2018-2025)
Figure Rest of South America Targeted Delivery Drugs Market Forecast (2018-2025)
Figure Middle East and Africa Targeted Delivery Drugs Market Forecast (2018-2025)
Figure Saudi Arabia Targeted Delivery Drugs Market Forecast (2018-2025)
Figure United Arab Emirates Targeted Delivery Drugs Market Forecast (2018-2025)
Figure Egypt Targeted Delivery Drugs Market Forecast (2018-2025)
Figure Nigeria Targeted Delivery Drugs Market Forecast (2018-2025)
Figure South Africa Targeted Delivery Drugs Market Forecast (2018-2025)
Figure Turkey Targeted Delivery Drugs Market Forecast (2018-2025)
Figure Rest of Middle East and Africa Targeted Delivery Drugs Market Forecast (2018-2025)
Figure Global Targeted Delivery Drugs Forecast by Type (2018-2025)
Figure Global Targeted Delivery Drugs Market Share Forecast by Type (2018-2025)
Figure Global Targeted Delivery Drugs Forecast by Type (2018-2025)
Figure Global Targeted Delivery Drugs Forecast by Application (2018-2025)
Figure Global Targeted Delivery Drugs Market Share Forecast by Application (2018-2025)
Figure Global Targeted Delivery Drugs Forecast by Application (2018-2025)

Please Note: Data related to the Companies are subject to Availability.

Research Methodology

We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.

Data Mining

Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.

Data Collection Matrix

Data Collection Matrix	Supply Side	Demand Side
Primary Data Sources	Manufacturers Distributors & Wholesalers GPOs	Physicians/Specialist Healthcare Providers Consumers
Secondary Data Sources	Annual Reports/SEC Filings/ Investor Presentations/ Press Releases Government/Associations Publications	Case Studies Reference Customers

Market Modeling and Forecasting

We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.

Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:

Number of patients for particular device or medical procedure and
Repeated use of particular device depending on health and condition of patient

Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.

We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.

Data Validation

We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.

Data Triangulation

data triangulation

Industry Analysis

Qualitative Data	Quantitative Data (2017-2025)
Market Dynamics (Drivers, Restraints, and Challenges) Industry Trend Analysis Market Opportunities Government Policies and Regulations, Patent Analysis, and Reimbursement Policies Porter’s Five Forces and PESTLE Analysis Key Developments and Competitive Landscape	Market Assessment and Forecast Market Assessment and Forecast, By Product Market Assessment and Forecast, By Technology Market Assessment and Forecast, By Application Market Assessment and Forecast, By End User Market Assessment and Forecast, By Region/Country

Request Sample Enquire Before Buying Request for Customization

Request Sample

Requirement/Comment